These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11745760)

  • 1. Cross-linked low molecular weight glycopeptide-mediated gene delivery: relationship between DNA metabolic stability and the level of transient gene expression in vivo.
    Yang Y; Park Y; Man S; Liu Y; Rice KG
    J Pharm Sci; 2001 Dec; 90(12):2010-22. PubMed ID: 11745760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates.
    Collard WT; Yang Y; Kwok KY; Park Y; Rice KG
    J Pharm Sci; 2000 Apr; 89(4):499-512. PubMed ID: 10737911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates.
    Kwok KY; Park Y; Yang Y; McKenzie DL; Liu Y; Rice KG
    J Pharm Sci; 2003 Jun; 92(6):1174-85. PubMed ID: 12761807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates.
    Adami RC; Rice KG
    J Pharm Sci; 1999 Aug; 88(8):739-46. PubMed ID: 10430535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates.
    Kwok KY; McKenzie DL; Evers DL; Rice KG
    J Pharm Sci; 1999 Oct; 88(10):996-1003. PubMed ID: 10514346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic PEGylated glycoproteins and their utility in gene delivery.
    Chen CP; Kim JS; Liu D; Rettig GR; McAnuff MA; Martin ME; Rice KG
    Bioconjug Chem; 2007; 18(2):371-8. PubMed ID: 17373767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery.
    Park Y; Kwok KY; Boukarim C; Rice KG
    Bioconjug Chem; 2002; 13(2):232-9. PubMed ID: 11906260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes.
    Anwer K; Logan M; Tagliaferri F; Wadhwa M; Monera O; Tung CH; Chen W; Leonard P; French M; Proctor B; Wilson E; Singhal A; Rolland A
    Pharm Res; 2000 Apr; 17(4):451-9. PubMed ID: 10870990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
    Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
    J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
    Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for maintaining the particle size of peptide DNA condensates following freeze-drying.
    Kwok KY; Adami RC; Hester KC; Park Y; Thomas S; Rice KG
    Int J Pharm; 2000 Aug; 203(1-2):81-8. PubMed ID: 10967430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
    Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells.
    Higuchi Y; Nishikawa M; Kawakami S; Yamashita F; Hashida M
    Int J Pharm; 2004 Dec; 287(1-2):147-54. PubMed ID: 15541921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-mediated gene delivery: influence of peptide structure on gene expression.
    Wadhwa MS; Collard WT; Adami RC; McKenzie DL; Rice KG
    Bioconjug Chem; 1997; 8(1):81-8. PubMed ID: 9026040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.
    Dong L; Gao S; Diao H; Chen J; Zhang J
    J Biomed Mater Res A; 2008 Mar; 84(3):777-84. PubMed ID: 17635017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral gene delivery for local and controlled DNA release.
    Trentin D; Hubbell J; Hall H
    J Control Release; 2005 Jan; 102(1):263-75. PubMed ID: 15653151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.
    Minayoshi Y; Maeda H; Yanagisawa H; Hamasaki K; Mizuta Y; Nishida K; Kinoshita R; Enoki Y; Imafuku T; Chuang VTG; Koga T; Fujiwara Y; Takeya M; Sonoda K; Wakayama T; Taguchi K; Ishima Y; Ishida T; Iwakiri Y; Tanaka M; Sasaki Y; Watanabe H; Otagiri M; Maruyama T
    Drug Deliv; 2018 Nov; 25(1):1067-1077. PubMed ID: 29688069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-Peptide Inhibition of Scavenger Receptor Uptake of Nanoparticles by the Liver.
    Allen RJ; Mathew B; Rice KG
    Mol Pharm; 2018 Sep; 15(9):3881-3891. PubMed ID: 30052459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
    Das S; Ng KY; Ho PC
    J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.
    Hirata K; Maruyama T; Watanabe H; Maeda H; Nakajou K; Iwao Y; Ishima Y; Katsumi H; Hashida M; Otagiri M
    J Control Release; 2010 Jul; 145(1):9-16. PubMed ID: 20304018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.